APH - Company ID 0000820313
The table below shows AMPHENOL CORP /DE/'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | $7.62B | $6.19B | $5.65B | $4.81B | $4.04B | $3.61B |
| Cost of revenue | $4.82B | $3.84B | $3.60B | $3.17B | $2.68B | $2.40B |
| Gross profit | $2.80B | $2.36B | $2.05B | $1.64B | $1.36B | $1.21B |
| R&D | - | - | - | - | - | - |
AMPHENOL CORP /DE/ reported annual revenue of $23.09B for fiscal year 2025. That is up 51.7% from $15.22B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $6.29B (FY 2016) to $23.09B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $851.50M |
| $657.00M |
| $622.50M |
| $575.20M |
| $492.00M |
| $444.30M |
| Operating income | $1.83B | $1.70B | $1.42B | $1.02B | $819.50M | $698.80M |
| Income tax | $702.40M | $385.80M | $247.30M | $218.70M | $166.10M | $135.10M |
| Net income | $933.00M | $1.25B | $1.09B | $737.80M | $604.40M | $524.80M |
| EPS (diluted) | $0.72 | $0.97 | $0.86 | $0.58 | $0.48 | $0.41 |